1LeSage MG, Keyler DE, Pentel PR. Current status of immunologic approaches to treating tobacco dependence:vaccines and nicotine-specific antibodies. AAPS J, 2006,8 (1) :E65-75.
2Hatsukami DK, Rennard S, Jorenby D, et al. Safety and immunogenicity of nicotine conjugate vaccine in current smokers. Clin Pharmacol Ther,2005,78(5) :456-467.
3Maurer P,Jennings GT,Willers J,et al. A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase Ⅰ safety and immunogenieity. Eur J Immunol,2005,35 (7) :2031-2040.
